WILLIAM PAULEY: Open Payments
NPI 1770002172 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$812 in 38 payments from 14 companies in 2025. Trend: 2023 $1,838 · 2024 $797 · 2025 $812
Food & beverage: $812
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $161 |
| Boston Scientific Corporation | 1 | $123 |
| Amgen Inc. | 5 | $73 |
| Lilly USA, LLC | 4 | $67 |
| ABBVIE INC. | 4 | $66 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Janssen Pharmaceuticals, Inc | 3 | $52 |
| PFIZER INC. | 3 | $46 |
| Abbott Laboratories | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
Products named: LUX-Dx Insertable Cardiac Monitor, REXULTI, Ozempic, MOUNJARO, Wegovy, SPRAVATO, EVENITY, FREESTYLE LIBRE 3.
Industry payments across VA — which companies pay providers there.
